By Stephanie Brown HealthDay ReporterTUESDAY, July 15, 2025 (HealthDay News) -- The U.S Food and Drug Administration has ...

The warning reflects growing concern over a surge in opioid products marketed to US consumers containing concentrated levels of 7-hydroxymitragynine (7-OH).

FDA announces bold warning requirement for opioid medication labels On Tuesday, the U.S. Food and Drug administration announced safety label changes for widely prescribed opioid pain medications.

A Kansas City company is illegally marketing pills that have opioid-like effects and could face possible action, the U.S. Food and Drug Administration wrote in a warning letter sent Tuesday.

The U.S. Food and Drug Administration sent letters to seven companies that sell opioid alternative products containing 7-hydroxymitragynine, also known as 7-OH. "This action reflects the Agency's ...

“There are no FDA-approved drugs containing 7-OH, and it is illegal to market any drugs containing 7-OH,” the FDA said.

The U.S. Food and Drug Administration is bringing attention to an unlawful dietary supplement that is turning up in online purchases and retail outlets.

The FDA is warning consumers about the dangers of tianeptine, a drug being sold at gas stations, ... such as opioid abuse and vaping addiction in youth," he continued.

WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; ULTRA-RAPID METABOLISM OF CODEINE AND OTHER RISK FACTORS FOR LIFE-THREATENING RESPIRATORY ...